BRCA Germline Mutations in Prostate Cancer: The Future Is Tailored

Diagnostics (Basel). 2021 May 19;11(5):908. doi: 10.3390/diagnostics11050908.

Authors

Felice Crocetto¹, Biagio Barone¹, Vincenzo Francesco Caputo¹, Matteo Fontana², Ottavio de Cobelli^{2

3}, Matteo Ferro²

Affiliations

¹ Department of Neurosciences, Reproductive Sciences and Odontostomatology, University of Naples "Federico II", 80131 Naples, Italy.
² Division of Urology, European Institute of Oncology, IRCSS, Milan, Via Ripamonti 435, 20141 Milan, Italy.
³ Department of Oncology and Hematology-Oncology, University of Milan, 20122 Milan, Italy.

Abstract

Prostate cancer (PCa) is the second most common neoplasm in men and the fifth leading cause of death worldwide [...].

Publication types

Editorial